Sarcoidosis presenting as optic neuritis with vision loss. 2023

Ryosuke Kataoka, and Yoshiro Kai, and Hiroya Ohara, and Hiromasa Hirai, and Kentaro Suzuki, and Masato Takano, and Yoshifumi Yamamoto, and Shigeo Muro
Department of Respiratory Medicine Minami-Nara General Medical Center Nara Japan.

Neurosarcoidosis is a rare complication of sarcoidosis and unusually presents as optic neuritis. We present the case of a 51-year-old man who complained of right vision loss. Brain magnetic resonance imaging showed asymmetrical enlargement of the right optic nerve. Chest computed tomography detected mediastinal and hilar lymphadenopathy. There were cutaneous nodules on the back. Biopsy of the mediastinal lymph node by endobronchial ultrasound-guided transbronchial needle aspiration and the skin showed noncaseating granulomas consistent with sarcoidosis. Serum angiotensin-converting enzyme level was elevated (34.2 IU/L) (normal: 8.3-21.4 IU/L). Based on these findings, he was diagnosed as neurosarcoidosis with optic neuritis. He was started on 1000-mg/day methylprednisolone intravenously for 3 days, followed by oral 50-mg/day prednisolone, which was gradually tapered for 8 weeks. Thereafter, the skin nodules and lymphadenopathy decreased and the right vision partially improved. Based on this rare case, sarcoidosis should be considered as a differential diagnosis in cases of optic neuritis.

UI MeSH Term Description Entries

Related Publications

Ryosuke Kataoka, and Yoshiro Kai, and Hiroya Ohara, and Hiromasa Hirai, and Kentaro Suzuki, and Masato Takano, and Yoshifumi Yamamoto, and Shigeo Muro
June 2020, Acta neurologica Belgica,
Ryosuke Kataoka, and Yoshiro Kai, and Hiroya Ohara, and Hiromasa Hirai, and Kentaro Suzuki, and Masato Takano, and Yoshifumi Yamamoto, and Shigeo Muro
June 2022, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace,
Ryosuke Kataoka, and Yoshiro Kai, and Hiroya Ohara, and Hiromasa Hirai, and Kentaro Suzuki, and Masato Takano, and Yoshifumi Yamamoto, and Shigeo Muro
October 2009, Australian family physician,
Ryosuke Kataoka, and Yoshiro Kai, and Hiroya Ohara, and Hiromasa Hirai, and Kentaro Suzuki, and Masato Takano, and Yoshifumi Yamamoto, and Shigeo Muro
December 2002, Korean journal of ophthalmology : KJO,
Ryosuke Kataoka, and Yoshiro Kai, and Hiroya Ohara, and Hiromasa Hirai, and Kentaro Suzuki, and Masato Takano, and Yoshifumi Yamamoto, and Shigeo Muro
November 2018, BMJ case reports,
Ryosuke Kataoka, and Yoshiro Kai, and Hiroya Ohara, and Hiromasa Hirai, and Kentaro Suzuki, and Masato Takano, and Yoshifumi Yamamoto, and Shigeo Muro
May 2023, Journal of neuroimmunology,
Ryosuke Kataoka, and Yoshiro Kai, and Hiroya Ohara, and Hiromasa Hirai, and Kentaro Suzuki, and Masato Takano, and Yoshifumi Yamamoto, and Shigeo Muro
December 1999, Indian journal of ophthalmology,
Ryosuke Kataoka, and Yoshiro Kai, and Hiroya Ohara, and Hiromasa Hirai, and Kentaro Suzuki, and Masato Takano, and Yoshifumi Yamamoto, and Shigeo Muro
April 1978, Annals of ophthalmology,
Ryosuke Kataoka, and Yoshiro Kai, and Hiroya Ohara, and Hiromasa Hirai, and Kentaro Suzuki, and Masato Takano, and Yoshifumi Yamamoto, and Shigeo Muro
April 2012, Therapeutic drug monitoring,
Ryosuke Kataoka, and Yoshiro Kai, and Hiroya Ohara, and Hiromasa Hirai, and Kentaro Suzuki, and Masato Takano, and Yoshifumi Yamamoto, and Shigeo Muro
June 2020, Ophthalmology and therapy,
Copied contents to your clipboard!